AOD-9604: Does not cause receptor burnout Does not require washout periods Does not lose effectiveness due to continuous use Consistency, not cycling, aligns with how it was designed to work
It should be noted that a significant portion of BPC-157 studies originate from a limited number of laboratories, primarily based in Croatia
1 With metformin and pioglitazone (AWARD-1) When added to metformin and pioglitazone, dulaglutide at doses of both 1.5mg and 750 microgram showed superiority to placebo and twice-daily exenatide for HbA 1c reduction at 26 weeks
This article compares their approaches, discusses when each model may be appropriate, and explains how genetic insights can support a more informed conversation with any providerincluding those at PlexusDx who work with compounded formulations
Someone who wants to market peptides for specific claim should be required to conduct trials
Precision auto-injection : The pen format ensures a consistent, measured dose every time with minimal discomfort and no wastage
